Skip to content
  • Select your language
    • English
    • French
    • Spanish
    • Italian
    • German
    • Japanese
    • Simplified Chinese

Language

Login/ Logout
Register
XH – Journey to a New era for Alzheimer’s Disease
  • Home
  • About the Program
  • Faculty
  • Ask a Question
Home About the Program Faculty Ask a Question

AD/PD™️ 2024 Lisbon, Portugal – March 5 – 9, 2024

Home > Home > AD/PD™️ 2024 Lisbon, Portugal – March 5 – 9, 2024

AD/PD focuses on basic science and translational and clinical research in Alzheimer’s disease and Parkinson’s disease, bringing key advances in disease mechanisms, innovative therapies, and diagnostic biomarkers.

Conference Content

News Nuggets
AD/PD™️ 2024 – 多奈单抗与阿杜那单抗相比,18 个月时淀粉样蛋白清除率有所提高
AD/PD™️ 2024 – 多奈单抗治疗下淀粉样蛋白清除率的基线淀粉样蛋白最重要的预测指标
AD/PD™️ 2024 – 研究突显了单独使用 p-tau 217 时和与 p-tau 231 结合使用时的预测能力
AD/PD™️ 2024 – 4 – 仑卡奈单抗对阿尔茨海默病的疾病修正效果可维持 24 个月
AD/PD™️ 2024 – Nugget 5 – 数据模型揭示了如何平衡多奈单抗的疗效和安全性
Breakfast Bytes - Video
AD/PD™️ 2024 – Breakfast Bite – Highlights of latest research on fluid biomarkers
AD/PD™️ 2024 – Breakfast Bite – Highlights research on earlier treatment with anti-amyloid immunotherapies
Breakfast Bytes - Podcast
AD/PD™️ 2024 – Breakfast Bite 1 – Podcast
AD/PD™️ 2024 – Breakfast Bite 2 – Podcast
Content Menu

Click to Provide Flash Feedback

12345678910
1 = poor, 10 = excellent
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Strongly disagreeDisagreeNeutralAgreeStrongly agree
YesNo
This field is for validation purposes and should be left unchanged.

喜欢这些内容?

加入本计划,即可获取高级认证内容,并在全年获得继续医学教育学分

立即注册

Privacy Policy
Terms and Conditions

Contact us: ime@springer.com

This activity is supported by an educational grant from Lilly.

This content was last updated on 3rd March 2024

Follow Us:

  • LinkedIn
  • Facebook
  • X

Manage cookie preferences

© 2024 Springer Healthcare Ltd | Website by Arttia Creative